Krishna Raghunathan

Chief Financial Officer

Professional Overview
Krishna Raghunathan is an accomplished finance executive with over 20 years of experience in the pharmaceutical and chemical industries. As the Chief Financial Officer at SUPRIYA LIFESCIENCE LIMITED, he is responsible for overseeing the company's financial strategy, reporting, and operations, contributing to its growth and profitability.

Experience Summary

Current Role
As the Chief Financial Officer at SUPRIYA LIFESCIENCE LIMITED since December 2022, Krishna is responsible for leading the company's financial strategy, ensuring efficient financial operations, and driving sustainable growth. He plays a critical role in managing the company's financial reporting, budgeting, and risk management processes, contributing to its success in the pharmaceutical industry.

Career Progression
Prior to his current role, Krishna held several senior finance positions, including Vice President of Finance, Treasury, and Investor Relations at Granules India Limited, Director of Finance for South and Southeast Asia (CFO) at AptarGroup, Inc., and Associate Director and Head of Global Finance for the Custom Pharmaceutical Services (CRAMS) division at Dr. Reddy's Laboratories. Throughout his career, he has demonstrated a strong track record of driving financial performance, optimizing processes, and contributing to the growth and profitability of the organizations he has served.

Academic Background
Krishna holds a bachelor's degree in commerce from the University of Madras and is a qualified Chartered Accountant from the Institute of Chartered Accountants of India.

Areas of Expertise

• Financial planning, budgeting, and reporting

• Treasury management and working capital optimization

• Mergers, acquisitions, and integration

• Investor relations and capital market transactions

• Strategic financial decision-making

• Risk management and compliance

Professional Impact
During his tenure at Granules India Limited, Krishna played a crucial role in streamlining the company's financial operations, improving cash flow management, and enhancing investor relations, contributing to the organization's successful growth and expansion. At AptarGroup, Inc., he was instrumental in driving the integration of acquired entities and aligning financial practices across the South and Southeast Asia region.

Conclusion
With his extensive experience in the pharmaceutical and chemical industries, Krishna Raghunathan is a seasoned finance executive who brings a strong strategic and operational focus to his role as Chief Financial Officer at SUPRIYA LIFESCIENCE LIMITED. His expertise in financial management, process optimization, and value creation positions him as a valuable asset to the company, contributing to its ongoing success and growth.